Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8213315 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 7 Pages |
Abstract
In the assessment of 50 patients with node-positive breast cancer treated with RT in a prospective clinical trial, decreased lung perfusion by SPECT/CT was demonstrated. Our study allowed for quantification of lung perfusion defects in a prospective cohort of breast cancer patients for whom attenuation-corrected SPECT/CT scans could be registered directly to RT treatment fields for precise dose estimates.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Adam L. MD, Robin B. CMD, Nirav S. MD, Daniel L. PhD, Virginia E. BS, James M. PhD, Jean M. PhD, Kristy K. PhD, Matt J. PhD, Reshma MD, DPhil, Kent A. MPH, MS, Kevin R. MD, MS, Kirk A. MD, PhD, Lori J. MD,